Using our Arestat™ technology platform, we are developing enhanced medicines for diabetes and other indications through our proprietary pipeline and in partnership with leading pharmaceutical and biotechnology companies

Our Products

Our potential products for diabetes and for specialist hospital use are designed to improve patient outcomes and enable healthier lives

Our Partners

We work with many of the top 20 leading pharmaceutical companies to enhance product formats, find solutions to development challenges and create differentiated products offering the potential for significant improvements in patient safety and convenience

Latest News and Events

  • 10th June 2021

    Arecor appoints Dr Lindsey Foulkes as Chief Operating Officer

  • 7th June 2021

    ARECOR ANNOUNCES EXCLUSIVE FORMULATION STUDY COLLABORATION WITH PAR

  • 20th May 2021

    ARECOR ANNOUNCES AN EXCLUSIVE FORMULATION STUDY COLLABORATION WITH LILLY